Access cutting-edge i cannot determine the primary medical condition from the provided information. the study title "abtect - maintenance" and the conditions listed only mention the drug abx464 and placebo, without specifying what medical condition is being treated. the brief summary section appears to contain only a localhost url rather than actual clinical information. treatment through this clinical trial at a research site in Little Rock. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Little Rock location
Access i cannot determine the primary medical condition from the provided information. the study title "abtect - maintenance" and the conditions listed only mention the drug abx464 and placebo, without specifying what medical condition is being treated. the brief summary section appears to contain only a localhost url rather than actual clinical information. specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related i cannot determine the primary medical condition from the provided information. the study title "abtect - maintenance" and the conditions listed only mention the drug abx464 and placebo, without specifying what medical condition is being treated. the brief summary section appears to contain only a localhost url rather than actual clinical information. treatment provided free
Check if you qualify for this i cannot determine the primary medical condition from the provided information. the study title "abtect - maintenance" and the conditions listed only mention the drug abx464 and placebo, without specifying what medical condition is being treated. the brief summary section appears to contain only a localhost url rather than actual clinical information. clinical trial in Little Rock, AR
No-Cost Study Care
Local to Little Rock
Convenient for AR residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This is a multicenter, randomized, placebo-controlled study to evaluate the long-term efficacy and safety of ABX464 50mg and 25mg administered once daily (QD) as maintenance therapy in subjects with moderately to severely active ulcerative colitis who have inadequate response, no response, a loss of response, or an intolerance to either conventional therapies \[corticosteroids, immunosuppressant (i.e. azathioprine, 6-mercaptopurine, methotrexate)\] and/or advanced therapies \[biologics (TNF inhi
Sponsor: Abivax S.A.
Yes, this clinical trial (NCT05535946) has an active research site in Little Rock, AR that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for i cannot determine the primary medical condition from the provided information. the study title "abtect - maintenance" and the conditions listed only mention the drug abx464 and placebo, without specifying what medical condition is being treated. the brief summary section appears to contain only a localhost url rather than actual clinical information. treatment options in Little Rock, AR, this clinical trial (NCT05535946) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Little Rock research site is actively enrolling participants for this clinical trial. You'll receive care from experienced i cannot determine the primary medical condition from the provided information. the study title "abtect - maintenance" and the conditions listed only mention the drug abx464 and placebo, without specifying what medical condition is being treated. the brief summary section appears to contain only a localhost url rather than actual clinical information. specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all i cannot determine the primary medical condition from the provided information. the study title "abtect - maintenance" and the conditions listed only mention the drug abx464 and placebo, without specifying what medical condition is being treated. the brief summary section appears to contain only a localhost url rather than actual clinical information. clinical trials near you to find additional studies recruiting in your area.
See all multiple myeloma clinical trials recruiting in Little Rock โ not just this study.
Browse Multiple Myeloma Trials in Little Rock โ